vandetanib
Showing 1 - 25 of 55
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory
Recruiting
- Advanced Malignant Neoplasm
- +3 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Invasive Breast Cancer Trial in Iowa City (Vandetanib, Placebo)
Terminated
- Invasive Breast Cancer
- Vandetanib
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 1, 2021
Thyroid Tumors Trial in Worldwide (Vandetanib, Placebo)
Active, not recruiting
- Thyroid Neoplasms
- Vandetanib
- Placebo
-
Brussels, Belgium
- +21 more
Oct 20, 2021
Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer Trial run by the NCI (Vandetanib, Metformin,
Terminated
- Renal Cell Carcinoma
- +2 more
- Vandetanib
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 12, 2021
Non Small Cell Lung Cancer Trial in Seoul (Vandetanib)
Completed
- Non Small Cell Lung Cancer
- Vandetanib
-
Seoul, Korea, Republic of
- +1 more
Dec 4, 2020
Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI
Completed
- Medullary Thyroid Carcinoma
- +2 more
- Vandetanib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 1, 2020
Locally Advanced or Metastatic Medullary Thyroid Cancer, Medullary Thyroid Cancer Trial in Worldwide (Patient outreach,
Active, not recruiting
- Locally Advanced or Metastatic Medullary Thyroid Cancer
- Medullary Thyroid Cancer
- Patient outreach
- Vandetanib
-
St Leonards, Australia
- +33 more
Oct 20, 2021
Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucous Carcinoma, Precancerous Condition Trial in Chicago (drug,
Completed
- Lip and Oral Cavity Squamous Cell Carcinoma
- +2 more
- vandetanib
- +5 more
-
Chicago, IllinoisUniversity of Chicago
Jan 8, 2021
Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)
Terminated
- Thyroid Cancer
- +5 more
- Lenvatinib
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021
Cancer of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Cancer of the Stomach Trial in Philadelphia
Completed
- Cancer of the Esophagus
- +2 more
- Vandetanib
- +4 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 4, 2021
GIST Trial run by the NCI (Vandetanib)
Completed
- GIST
- Vandetanib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 25, 2020
Cancer, High-grade Glioma Trial in Amsterdam (Sunitinib, vandetanib, Erlotinib)
Unknown status
- Cancer
- High-grade Glioma
- Sunitinib
- +2 more
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Oct 6, 2020
NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- AZD2014
- +10 more
-
Avignon, France
- +36 more
Jul 29, 2022
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Non Small Cell Lung Cancer, Lung Cancer Trial in Worldwide (Vandetanib, Pemetrexed)
Active, not recruiting
- Non Small Cell Lung Cancer
- Lung Cancer
- Vandetanib
- Pemetrexed
-
Casa Grande, Arizona
- +109 more
Oct 20, 2021
Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor, Relapsed Pediatric AML Trial in Seoul (CancerSCAN™,
Recruiting
- Relapsed Pediatric Solid Tumor
- +3 more
- CancerSCAN™
- +17 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 18, 2020
Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)
Recruiting
- Medullary Thyroid Cancer
- Selpercatinib
- +2 more
-
Birmingham, Alabama
- +148 more
Jan 18, 2023
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,
Completed
- Bladder Cancer
- +3 more
- carboplatin
- +3 more
-
Glasgow, Scotland, United Kingdom
- +20 more
May 14, 2019
Medullary Thyroid Carcinoma Trial run by the NCI (Bortezomib, Vandetanib)
Terminated
- Medullary Thyroid Carcinoma
- Bortezomib
- Vandetanib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 5, 2018
Transitional Cell Carcinoma, Bladder Cancer Trial in Boston (Docetaxel, vandetanib, Placebo)
Completed
- Transitional Cell Carcinoma
- Bladder Cancer
- Docetaxel
- +2 more
-
Boston, Massachusetts
- +2 more
Aug 20, 2018
Colorectal, Cancer Trial in Worldwide (Vandetanib, FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid)
Completed
- Colorectal
- Cancer
- Vandetanib
- FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid
-
Lille Cedex, France
- +14 more
Jan 24, 2018
Medullary Thyroid Cancer Trial in Overland Park (vandetanib, omeprazole, ranitidine)
Completed
- Medullary Thyroid Cancer
- vandetanib
- +2 more
-
Overland Park, KansasResearch Site
Apr 28, 2017
Breast Cancer Trial in Stanford (Vandetanib, Anastrozole)
Terminated
- Breast Cancer
- Vandetanib
- Anastrozole
-
Stanford, CaliforniaStanford University School of Medicine
Dec 13, 2016